LLY

947.62

-2.8%↓

JNJ

221.12

-0.62%↓

ABBV

201.14

-0.71%↓

UNH

379.44

+2.66%↑

AZN

182.32

+0.05%↑

LLY

947.62

-2.8%↓

JNJ

221.12

-0.62%↓

ABBV

201.14

-0.71%↓

UNH

379.44

+2.66%↑

AZN

182.32

+0.05%↑

LLY

947.62

-2.8%↓

JNJ

221.12

-0.62%↓

ABBV

201.14

-0.71%↓

UNH

379.44

+2.66%↑

AZN

182.32

+0.05%↑

LLY

947.62

-2.8%↓

JNJ

221.12

-0.62%↓

ABBV

201.14

-0.71%↓

UNH

379.44

+2.66%↑

AZN

182.32

+0.05%↑

LLY

947.62

-2.8%↓

JNJ

221.12

-0.62%↓

ABBV

201.14

-0.71%↓

UNH

379.44

+2.66%↑

AZN

182.32

+0.05%↑

Home・Stock List・Adverum Biotechnologies Inc

Search

Adverum Biotechnologies Inc

Closed

SectorHealthcare

0

Overview

Share price change

24h

Current

Min

Max

Recommendations
By TipRanks
Recommendations	Buy
12 Months Forecast	+11.93% upside

News Sentiment

By Acuity

50%

50%

159 / 347 Healthcare

Adverum Biotechnologies Inc Chart

Past performance is not a reliable indicator of future results.

Related News

24 Oct 2025, 13:04 UTC

Acquisitions, Mergers, Takeovers

Eli Lilly Agrees to Acquire Adverum Biotechnologies

9 Dec 2025, 13:32 UTC

Acquisitions, Mergers, Takeovers

Eli Lilly: Parties Expect to Consummate the Acquisition on Dec 9 >LLY

9 Dec 2025, 13:32 UTC

Acquisitions, Mergers, Takeovers

Lilly and Purchaser Accepted for Payment, and Will Promptly Pay, for All Shrs

9 Dec 2025, 13:29 UTC

Acquisitions, Mergers, Takeovers

Lilly and Adverum Announce Expiration and Completion of Adverum Tender Offer and Acquisition

24 Oct 2025, 12:34 UTC

Acquisitions, Mergers, Takeovers

Eli Lilly Says Transaction Is Expected to Close in the 4Q >LLY

24 Oct 2025, 12:34 UTC

Acquisitions, Mergers, Takeovers

Eli Lilly: Offer Also Includes 1 Non-Transferrable Contingent Value Right Entitling Holder to Receive Up to an Additional $8.91 Per CVR in Cash Upon the Achievement of 2 Milestones, for Total Potential Consideration of Up to $12.47/Shr >LLY

24 Oct 2025, 12:33 UTC

Acquisitions, Mergers, Takeovers

Eli Lilly to Launch Tender Offer to Acquire All Outstanding Shares of Adverum for $3.56/Shr >LLY

24 Oct 2025, 12:30 UTC

Acquisitions, Mergers, Takeovers

Lilly To Acquire Adverum Biotechnologies >LLY ADVM

Peer Comparison

Price change

Adverum Biotechnologies Inc Forecast

Price Target

By TipRanks

11.93% upside

12 Months Forecast

Average 4.88 USD 11.93%

High 5.5 USD

Low 4 USD

Based on 5 Wall Street analysts offering 12 month price targets forAdverum Biotechnologies Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

5 ratings

2

Buy

3

Hold

0

Sell

Based on 5 analysts giving stock ratings to Adverum Biotechnologies Inc - Dist in the past 3 months.

Sentiment

By Acuity

159 / 347 Healthcare

Financials

$

Other stocks from the sector

LLY

Eli Lilly and Co.

947.62

JNJ

Johnson and Johnson

221.12

ABBV

AbbVie Inc

201.14

UNH

UnitedHealth Group Inc

379.44

AZN

AstraZeneca PLC

182.32

Live chat